BIND

BIND Therapeutics, Inc. News Headlines

$8.02
*  
0.92
10.29%
Get BIND Alerts
*Delayed - data as of Oct. 31, 2014 15:54 ET  -  Find a broker to begin trading BIND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIND After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape
10/31/2014 9:11:00 AM - Zacks.com


Innovative Australian Companies On Canaccord Analyst Matthijs Smith's Opportunity List
8/28/2014 3:58:00 PM - Seeking Alpha


Medivation Set To Go Higher As Prostate Cancer Drug Xtandi Quickly Approaches Blockbuster Status
7/10/2014 2:03:00 PM - Seeking Alpha


BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape
7/7/2014 8:44:00 AM - Zacks.com


BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog
7/3/2014 4:30:00 PM - Zacks.com


Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on Cancer Treatment
7/3/2014 1:07:17 PM - MT Newswires


Sector Update: Healthcare
7/3/2014 1:06:40 PM - MT Newswires


BIND Therapeutics (BIND) Soars: Stock Adds 9.1% in Session - Tale of the Tape
6/30/2014 9:39:00 AM - Zacks.com


BIND Therapeutics (BIND) Soars: Stock Up 6.8% - Tale of the Tape
6/13/2014 9:39:00 AM - Zacks.com


BIND Therapeutics Set To Revolutionize Drug Treatment As Clinical Data Continues To Impress
6/11/2014 10:58:00 AM - Seeking Alpha


A Handful Of Nanotechnology Companies Looking Very Attractive For Investors
5/9/2014 3:45:00 AM - Seeking Alpha


Company news for March 26, 2014 - Corporate Summary
3/26/2014 10:06:01 AM - Zacks.com


BIND Therapeutics Is Worth $18/Share
2/14/2014 9:46:00 AM - Seeking Alpha


Is BIND Therapeutics Ready To Fly Higher?
12/12/2013 4:25:00 PM - Seeking Alpha


BIND Therapeutics Had A Muted IPO But The Thesis Intrigues
10/8/2013 2:17:00 PM - Seeking Alpha


Insiders at Synageva BioPharma and Bind Therapeutics Buy Shares
9/30/2013 10:12:00 AM - Minyanville


Bind Therapeutics - Cancer Research IPOs Are The Hottest Things In Town
9/23/2013 6:36:00 PM - Seeking Alpha


BIND Therapeutics prices IPO at $15, within the range
9/19/2013 6:29:47 PM - Renaissance Capital


IPO Preview: BIND Therapeutics
9/19/2013 5:56:00 PM - Seeking Alpha


Bind's IPO: A Revolution In Drug Delivery
9/19/2013 5:00:00 PM - Seeking Alpha


12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha


12 US IPOs planned for the week of Sep 16
9/16/2013 11:47:34 AM - Renaissance Capital


U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha


US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds
9/8/2013 10:23:54 PM - Renaissance Capital


Cancer biotech BIND Therapeutics sets terms for $71 million IPO
9/5/2013 4:24:59 PM - Renaissance Capital